{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T09:05:11Z","timestamp":1766653511245,"version":"3.48.0"},"reference-count":47,"publisher":"Walter de Gruyter GmbH","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,25]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_dmpt-2025-0049_abs_001\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Diabetes mellitus is a complex metabolic disease characterised by chronic hyperglycaemia, which triggers a cascade of pathological changes in the body. Contemporary methods for developing antidiabetic drugs are often lengthy, expensive, and not always effective. The use of neural networks for modelling diabetes opens up new possibilities for accelerating research and increasing the accuracy of predicting the effectiveness of novel therapeutic strategies. The aim of this study was to develop and validate a neural network for studying experimental diabetes and assessing the efficacy of new antidiabetic drugs, as well as to explore the potential of combined therapeutic strategies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_dmpt-2025-0049_abs_002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The empirical investigation was conducted using laboratory models of diabetes induced in rats with streptozotocin. Three groups were formed: a control group, a diabetic group without treatment, and a diabetic group treated with experimental\u00a0drugs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_dmpt-2025-0049_abs_003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A neural network, based on multilayer perceptrons and recurrent architectures, was trained to predict changes in glucose levels, oxidative stress markers, and the condition of pancreatic tissues. The developed model demonstrated high predictive accuracy of metabolic changes, with an average accuracy of 92.3\u202f%. As a result of treatment with experimental drugs, blood glucose levels in rats decreased by 25\u201330\u202f% over 28\u00a0days, accompanied by a 26\u202f% reduction in oxidative stress markers and partial restoration of pancreatic \u03b2-cell function in 30\u202f% of cases. Histological analysis confirmed reduced fibrosis and improved tissue condition in the treatment group. The model also identified that combined therapeutic strategies\u00a0\u2013\u00a0for example, the combination of antioxidants with gluconeogenesis inhibitors\u00a0\u2013\u00a0had a synergistic effect, lowering glucose levels by up to 40\u202f%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_dmpt-2025-0049_abs_004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The study confirmed the effectiveness of the developed neural network for analysing therapeutic strategies and predicting metabolic changes in diabetes models. The proposed neural network represents a promising tool for investigating new antidiabetic drugs, including efficacy assessment within personalised medicine. Its application may accelerate preclinical research, optimise therapeutic approaches, and contribute to reducing drug development\u00a0costs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/dmpt-2025-0049","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T15:44:44Z","timestamp":1763394284000},"page":"231-241","source":"Crossref","is-referenced-by-count":1,"title":["Neural network modelling of experimental diabetes to study new antidiabetic drugs"],"prefix":"10.1515","volume":"40","author":[{"given":"Zhansulu","family":"Nurgaliyeva","sequence":"first","affiliation":[{"name":"Department of Pharmacology , 374640 Kazakh-Russian Medical University , Almaty , Republic of Kazakhstan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayazhan","family":"Dauletkaliyeva","sequence":"additional","affiliation":[{"name":"Department of Information Technology , Al-Farabi Kazakh National University , Almaty , Republic of Kazakhstan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serzhan","family":"Dauletkaliyev","sequence":"additional","affiliation":[{"name":"Department of Pediatrics , Kazakh National Medical University named after S.D. Asfendiyarov , Almaty , Republic of Kazakhstan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dana","family":"Tolegen","sequence":"additional","affiliation":[{"name":"Department of Pediatrics , Kazakh National Medical University named after S.D. Asfendiyarov , Almaty , Republic of Kazakhstan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rauza","family":"Romanova","sequence":"additional","affiliation":[{"name":"Department of Pharmacology , 374640 Kazakh-Russian Medical University , Almaty , Republic of Kazakhstan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"key":"2025122507573916093_j_dmpt-2025-0049_ref_001","unstructured":"World Health Organization. Diabetes; 2024. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/diabetes."},{"key":"2025122507573916093_j_dmpt-2025-0049_ref_002","doi-asserted-by":"crossref","unstructured":"Tazhbenova, ST, Millere, I, Yermukhanova, LS, Sultanova, G, Turebaev, M, Sultanova, BP. Effectiveness of diabetes mellitus management program at primary health care level. Elect J Gen Med 2019;16:em172. https:\/\/doi.org\/10.29333\/ejgm\/115848.","DOI":"10.29333\/ejgm\/115848"},{"key":"2025122507573916093_j_dmpt-2025-0049_ref_003","doi-asserted-by":"crossref","unstructured":"Turdybekov, KM, Gafurov, NM, Adekenov, SM, Struchkov, YT. Photochemical transformation of hanphilline and crystal structure of 1(10)Z,4Z-hanphilline. Mendeleev Commun 1994;4:81\u20132. https:\/\/doi.org\/10.1070\/MC1994v004n03ABEH000356.","DOI":"10.1070\/MC1994v004n03ABEH000356"},{"key":"2025122507573916093_j_dmpt-2025-0049_ref_004","unstructured":"Jahangir, Z, Shah, YAR, Qureshi, SM, Qureshi, HA, Shah, SUR, Naguib, JS. From data to decisions: the AI revolution in diabetes care. Int J Membr Sci Technol 2023;10:1162\u201379. https:\/\/doi.org\/10.15379\/ijmst.v10i5.3766."},{"key":"2025122507573916093_j_dmpt-2025-0049_ref_005","doi-asserted-by":"crossref","unstructured":"Merkhatuly, N, Iskanderov, A, Abeuova, S, Iskanderov, A, Zhokizhanova, S. Introduction of electron donor groups into the azulene structure: the appearance of intense absorption and emission in the visible region. Molecules 2024;29:3354. https:\/\/doi.org\/10.3390\/molecules29143354.","DOI":"10.3390\/molecules29143354"},{"key":"2025122507573916093_j_dmpt-2025-0049_ref_006","doi-asserted-by":"crossref","unstructured":"Tkach, VV, Kushnir, MV, de Oliveira, SC, Zavhorodnii, MP, Brazhko, OA, Kornet, MM, et al.. The theoretical description for a sucralose electrochemical cathodical determination over a 9-9\u00b4-diacridyl-modified electrode. Orbit 2021;13:219\u201322. https:\/\/doi.org\/10.17807\/orbital.v13i3.1584.","DOI":"10.17807\/orbital.v13i3.1584"},{"key":"2025122507573916093_j_dmpt-2025-0049_ref_007","doi-asserted-by":"crossref","unstructured":"Tkach, VV, Kushnir, MV, de Oliveira, SC, Ivanushko, YG, Velyka, AV, Molodianu, AF, et al.. Electrochemical determination of Sudan dyes and two manner to realize it: a theoretical investigation. Lett Appl NanoBioSci 2020;9:1451\u20138. https:\/\/doi.org\/10.33263\/LIANBS94.14511458.","DOI":"10.33263\/LIANBS94.14511458"},{"key":"2025122507573916093_j_dmpt-2025-0049_ref_008","unstructured":"International Diabetes Federation. Facts & figures; 2025. https:\/\/idf.org\/about-diabetes\/diabetes-facts-figures\/."},{"key":"2025122507573916093_j_dmpt-2025-0049_ref_009","doi-asserted-by":"crossref","unstructured":"Guo, Q, Fu, B, Tian, Y, Xu, S, Meng, X. Recent progress in artificial intelligence and machine learning for novel diabetes mellitus medications development. Curr Med Res Opin 2024;40:1483\u201393. https:\/\/doi.org\/10.1080\/03007995.2024.2387187.","DOI":"10.1080\/03007995.2024.2387187"},{"key":"2025122507573916093_j_dmpt-2025-0049_ref_010","doi-asserted-by":"crossref","unstructured":"Ali, G, Dastgir, A, Iqbal, MW, Anwar, M, Faheem, M. A hybrid convolutional neural network model for automatic diabetic retinopathy classification from fundus images. IEEE J Transl Eng Health Med 2023;11:341\u201350. https:\/\/doi.org\/10.1109\/JTEHM.2023.3282104.","DOI":"10.1109\/JTEHM.2023.3282104"},{"key":"2025122507573916093_j_dmpt-2025-0049_ref_011","doi-asserted-by":"crossref","unstructured":"Luo, M, Wang, YT, Wang, XK, Hou, WH, Huang, RL, Liu, Y, et al.. A multi-granularity convolutional neural network model with temporal information and attention mechanism for efficient diabetes medical cost prediction. Comput Biol Med 2022;151:106246. https:\/\/doi.org\/10.1016\/j.compbiomed.2022.106246.","DOI":"10.1016\/j.compbiomed.2022.106246"},{"key":"2025122507573916093_j_dmpt-2025-0049_ref_012","doi-asserted-by":"crossref","unstructured":"Masud, M, Alhamid, MF, Zhang, Y. A convolutional neural network model using weighted loss function to detect diabetic retinopathy. ACM Trans Multimed Comput Commun Appl 2022;18:1\u201316. https:\/\/doi.org\/10.1145\/3470976.","DOI":"10.1145\/3470976"},{"key":"2025122507573916093_j_dmpt-2025-0049_ref_013","doi-asserted-by":"crossref","unstructured":"Hoyos, W, Hoyos, K, Ruiz, R, Aguilar, J. An explainable analysis of diabetes mellitus using statistical and artificial intelligence techniques. BMC Med Inf Decis Making 2024;24:383. https:\/\/doi.org\/10.1186\/s12911-024-02810-x.","DOI":"10.1186\/s12911-024-02810-x"},{"key":"2025122507573916093_j_dmpt-2025-0049_ref_014","doi-asserted-by":"crossref","unstructured":"Ellahham, S. Artificial intelligence: the future for diabetes care. Am J Med 2020;133:895\u2013900. https:\/\/doi.org\/10.1016\/j.amjmed.2020.03.033.","DOI":"10.1016\/j.amjmed.2020.03.033"},{"key":"2025122507573916093_j_dmpt-2025-0049_ref_015","doi-asserted-by":"crossref","unstructured":"Li, X. Artificial intelligence neural network based on intelligent diagnosis. J\u00a0Ambient Intell Hum Comput 2021;12:923\u201331. https:\/\/doi.org\/10.1007\/s12652-020-02108-6.","DOI":"10.1007\/s12652-020-02108-6"},{"key":"2025122507573916093_j_dmpt-2025-0049_ref_016","doi-asserted-by":"crossref","unstructured":"Dubey, VN, Dave, JM, Beavis, J, Coppini, DV. Predicting diabetic neuropathy risk level using artificial neural network and clinical parameters of subjects with diabetes. J\u00a0Diabetes Sci Technol 2020;16:275\u201381. https:\/\/doi.org\/10.1177\/1932296820965583.","DOI":"10.1177\/1932296820965583"},{"key":"2025122507573916093_j_dmpt-2025-0049_ref_017","doi-asserted-by":"crossref","unstructured":"Srinivasu, PN, Ahmed, S, Hassaballah, M, Almusallam, N. An explainable artificial intelligence software system for predicting diabetes. Heliyon 2024;10:e36112. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e36112.","DOI":"10.1016\/j.heliyon.2024.e36112"},{"key":"2025122507573916093_j_dmpt-2025-0049_ref_018","doi-asserted-by":"crossref","unstructured":"Galiyeva, D, Gusmanov, A, Sakko, Y, Issanov, A, Atageldiyeva, K, Kadyrzhanuly, K, et al.. Epidemiology of type 1 and type 2 diabetes mellitus in Kazakhstan: data from unified national electronic health system 2014\u20132019. BMC Endocr Disord 2022;22:275. https:\/\/doi.org\/10.1186\/s12902-022-01200-6.","DOI":"10.1186\/s12902-022-01200-6"},{"key":"2025122507573916093_j_dmpt-2025-0049_ref_019","unstructured":"Centers for Disease Control and Prevention. National diabetes statistics report; 2025. https:\/\/www.cdc.gov\/diabetes\/php\/data-research\/index.html."},{"key":"2025122507573916093_j_dmpt-2025-0049_ref_020","unstructured":"Herrerot, M. DDR dataset: the DDR dataset preprocessed; 2022. https:\/\/www.kaggle.com\/datasets\/mariaherrerot\/ddrdataset."},{"key":"2025122507573916093_j_dmpt-2025-0049_ref_021","unstructured":"European Convention for the Protection of Vertebrate Animals Used for Experimental and Other Scientific Purposes; 1986. https:\/\/rm.coe.int\/168007a67b."},{"key":"2025122507573916093_j_dmpt-2025-0049_ref_022","doi-asserted-by":"crossref","unstructured":"Du Sert, NP, Ahluwalia, A, Alam, S, Avey, MT, Baker, M, Browne, WJ, et al.. Reporting animal research: explanation and elaboration for the ARRIVE guidelines 2.0. PLoS Biol 2020;18:e3000411. https:\/\/doi.org\/10.1371\/journal.pbio.3000411.","DOI":"10.1371\/journal.pbio.3000411"},{"key":"2025122507573916093_j_dmpt-2025-0049_ref_023","doi-asserted-by":"crossref","unstructured":"Lewandowski, K, Rydzewska, G, Ledwo\u0144, TK. Preparation for endoscopic examinations in patients with diabetes and hypoglycaemia. Przegl\u0105d Gastroenterol 2021;16:297\u2013305. https:\/\/doi.org\/10.5114\/pg.2021.111763.","DOI":"10.5114\/pg.2021.111763"},{"key":"2025122507573916093_j_dmpt-2025-0049_ref_024","doi-asserted-by":"crossref","unstructured":"Firdauzi, GI, Vidyani, A, Mufida, AZ, Widodo, B, Purbayu, H, Thamrin, H, et al.. Diagnostic problem of hyperbilirubinemia in diabetes mellitus patient: case report. Gac Med Caracas 2025;133:234\u201342. https:\/\/doi.org\/10.47307\/GMC.2025.133.1.21.","DOI":"10.47307\/GMC.2025.133.1.21"},{"key":"2025122507573916093_j_dmpt-2025-0049_ref_025","doi-asserted-by":"crossref","unstructured":"Ningsih, OS, Efendi, F, Dewi, YS. Factors associated with diabetes distress and depression in diabetes mellitus patients in rural East Nusa Tenggara Indonesia. Gac Med Caracas 2024;132:s179\u201386. https:\/\/doi.org\/10.47307\/GMC.2024.132.s2.3.","DOI":"10.47307\/GMC.2024.132.s2.3"},{"key":"2025122507573916093_j_dmpt-2025-0049_ref_026","doi-asserted-by":"crossref","unstructured":"Koshechkin, KA, Yavorsky, AN. New opportunities for the application of artificial intelligence in pharmacology. Exp Clin Pharmacol 2023;86:85. https:\/\/doi.org\/10.30906\/ekf-2023-86s-85.","DOI":"10.30906\/ekf-2023-86s-85"},{"key":"2025122507573916093_j_dmpt-2025-0049_ref_027","doi-asserted-by":"crossref","unstructured":"Vasilyev, PM. Artificial intelligence in the search for pharmacologically active substances. Exp Clin Pharmacol 2023;86:25. https:\/\/doi.org\/10.30906\/ekf-2023-86s-25.","DOI":"10.30906\/ekf-2023-86s-25"},{"key":"2025122507573916093_j_dmpt-2025-0049_ref_028","doi-asserted-by":"crossref","unstructured":"Bolatchiev, AD, Baturin, VA, Shchetinin, EV, Bolatchieva, YV. Search and development of new peptide compounds with pharmacological activity using artificial intelligence methods. Exp Clin Pharmacol 2023;86:20. https:\/\/doi.org\/10.30906\/ekf-2023-86s-20.","DOI":"10.30906\/ekf-2023-86s-20"},{"key":"2025122507573916093_j_dmpt-2025-0049_ref_029","doi-asserted-by":"crossref","unstructured":"Gangwal, A, Ansari, A, Ahmad, I, Azad, AK, Kumarasamy, V, Subramaniyan, V, et al.. Generative artificial intelligence in drug discovery: basic framework, recent advances, challenges, and opportunities. Front Pharmacol 2024;15:1331062. https:\/\/doi.org\/10.3389\/fphar.2024.1331062.","DOI":"10.3389\/fphar.2024.1331062"},{"key":"2025122507573916093_j_dmpt-2025-0049_ref_030","unstructured":"Polak, S, Skowron, A, Mendyk, A, Brandys, J. Artificial neural network in pharmacoeconomics. In: Duolaga, M, Zieli\u0144ski, K, Ingram, D, editors. Stud Health Technol Inform. Amsterdam: IOS Press; 2004:241\u201352 pp."},{"key":"2025122507573916093_j_dmpt-2025-0049_ref_031","doi-asserted-by":"crossref","unstructured":"Jakovljevic, M, Matter-Walstra, K, Sugahara, T, Sharma, T, Reshetnikov, V, Merrick, J, et al.. Cost-effectiveness and resource allocation (CERA) 18\u00a0years of evolution: maturity of adulthood and promise beyond tomorrow. Cost Eff Resour Allocation 2020;18:15. https:\/\/doi.org\/10.1186\/s12962-020-00210-2.","DOI":"10.1186\/s12962-020-00210-2"},{"key":"2025122507573916093_j_dmpt-2025-0049_ref_032","doi-asserted-by":"crossref","unstructured":"Kosherbayeva, L, Medeulova, A, Hailey, D, Yermukhanova, L, Uraz, R, Aitmanbetova, A. Influence of a health technology assessment on the use of pediatric cochlear implantation in Kazakhstan. Health Pol Tech 2018;7:239\u201342. https:\/\/doi.org\/10.1016\/j.hlpt.2018.06.002.","DOI":"10.1016\/j.hlpt.2018.06.002"},{"key":"2025122507573916093_j_dmpt-2025-0049_ref_033","doi-asserted-by":"crossref","unstructured":"Bogoyavlenskiy, A, Alexyuk, M, Alexyuk, P, Berezin, V, Almalki, FA, Ben, HT, et al.. Computer analysis of the inhibition of ACE2 by flavonoids and identification of their potential antiviral pharmacophore site. Molecules 2023;28:3766. https:\/\/doi.org\/10.3390\/molecules28093766.","DOI":"10.3390\/molecules28093766"},{"key":"2025122507573916093_j_dmpt-2025-0049_ref_034","doi-asserted-by":"crossref","unstructured":"Elvidge, J, Hawksworth, C, Sayg\u0131n Av\u015far, T, Zemplenyi, A, Chalkidou, A, Petrou, S, et al.. Consolidated health economic evaluation reporting standards for interventions that use artificial intelligence (CHEERS-AI). Value Health 2024;27:11996\u20131205. https:\/\/doi.org\/10.1016\/j.jval.2024.05.006.","DOI":"10.1016\/j.jval.2024.05.006"},{"key":"2025122507573916093_j_dmpt-2025-0049_ref_035","doi-asserted-by":"crossref","unstructured":"Yamada, T, Iwasaki, K, Maedera, S, Ito, K, Takeshima, T, Noma, H, et al.. Myocardial infarction in type 2 diabetes using sodium-glucose co-transporter-2 inhibitors, dipeptidyl peptidase-4 inhibitors or glucagon-like peptide-1 receptor agonists: proportional hazards analysis by deep neural network based machine learning. Curr Med Res Opin 2020;36:403\u20139. https:\/\/doi.org\/10.1080\/03007995.2019.1706043.","DOI":"10.1080\/03007995.2019.1706043"},{"key":"2025122507573916093_j_dmpt-2025-0049_ref_036","doi-asserted-by":"crossref","unstructured":"Odugbemi, AI, Nyirenda, C, Christoffels, A, Egieyeh, SA. Artificial intelligence in antidiabetic drug discovery: the advances in QSAR and the prediction of \u03b1-glucosidase inhibitors. Comput Struct Biotechnol J 2024;23:2964\u201377. https:\/\/doi.org\/10.1016\/j.csbj.2024.07.003.","DOI":"10.1016\/j.csbj.2024.07.003"},{"key":"2025122507573916093_j_dmpt-2025-0049_ref_037","doi-asserted-by":"crossref","unstructured":"Zhu, S, Bai, Q, Li, L, Xu, T. Drug repositioning in drug discovery of T2DM and repositioning potential of antidiabetic agents. Comput Struct Biotechnol J 2022;20:2839\u201347. https:\/\/doi.org\/10.1016\/j.csbj.2022.05.057.","DOI":"10.1016\/j.csbj.2022.05.057"},{"key":"2025122507573916093_j_dmpt-2025-0049_ref_038","doi-asserted-by":"crossref","unstructured":"Liu, XW, Shi, TY, Gao, D, Ma, CY, Lin, H, Yan, D, et al.. iPADD: a computational tool for predicting potential antidiabetic drugs using machine learning algorithms. J\u00a0Chem Inf Model 2023;63:4960\u20139. https:\/\/doi.org\/10.1021\/acs.jcim.3c00564.","DOI":"10.1021\/acs.jcim.3c00564"},{"key":"2025122507573916093_j_dmpt-2025-0049_ref_039","doi-asserted-by":"crossref","unstructured":"Kang, S. Personalized prediction of drug efficacy for diabetes treatment via patient-level sequential modeling with neural networks. Artif Intell Med 2018;85:1\u20136. https:\/\/doi.org\/10.1016\/j.artmed.2018.02.004.","DOI":"10.1016\/j.artmed.2018.02.004"},{"key":"2025122507573916093_j_dmpt-2025-0049_ref_040","doi-asserted-by":"crossref","unstructured":"Derakhshan, MS, Sohrabi, MR, Davallo, M. Developed rapid spectrophotometric method for simultaneous quantitative determination of metformin and linagliptin mixture as antidiabetic drugs by artificial intelligence methodology in biological fluid and pharmaceutical sample. Optik 2021;241:166922. https:\/\/doi.org\/10.1016\/j.ijleo.2021.166922.","DOI":"10.1016\/j.ijleo.2021.166922"},{"key":"2025122507573916093_j_dmpt-2025-0049_ref_041","doi-asserted-by":"crossref","unstructured":"Gong, JN, Zhao, L, Chen, G, Chen, X, Chen, ZD, Chen, CYC. A novel artificial intelligence protocol to investigate potential leads for diabetes mellitus. Mol Divers 2021;25:1375\u201393. https:\/\/doi.org\/10.1007\/s11030-021-10204-8.","DOI":"10.1007\/s11030-021-10204-8"},{"key":"2025122507573916093_j_dmpt-2025-0049_ref_042","doi-asserted-by":"crossref","unstructured":"Zhou, H, Myrzashova, R, Zheng, R. Diabetes prediction model based on an enhanced deep neural network. EURASIP J Wirel Commun Netw 2020;2020:148. https:\/\/doi.org\/10.1186\/s13638-020-01765-7.","DOI":"10.1186\/s13638-020-01765-7"},{"key":"2025122507573916093_j_dmpt-2025-0049_ref_043","doi-asserted-by":"crossref","unstructured":"Ali, JB, Hamdi, T, Fnaiech, N, Di Costanzo, V, Fnaiech, F, Ginoux, JM. Continuous blood glucose level prediction of type 1 diabetes based on artificial neural network. Biocybern Biomed Eng 2018;38:828\u201340. https:\/\/doi.org\/10.1016\/j.bbe.2018.06.005.","DOI":"10.1016\/j.bbe.2018.06.005"},{"key":"2025122507573916093_j_dmpt-2025-0049_ref_044","doi-asserted-by":"crossref","unstructured":"Sarwar, A, Ali, M, Manhas, J, Sharma, V. Diagnosis of diabetes type-II using hybrid machine learning based ensemble model. Int J Inf Technol 2020;12:419\u201328. https:\/\/doi.org\/10.1007\/s41870-018-0270-5.","DOI":"10.1007\/s41870-018-0270-5"},{"key":"2025122507573916093_j_dmpt-2025-0049_ref_045","doi-asserted-by":"crossref","unstructured":"Gadekallu, TR, Khare, N, Bhattacharya, S, Singh, S, Maddikunta, PKR, Srivastava, G. Deep neural networks to predict diabetic retinopathy. J\u00a0Ambient Intell Hum Comput 2023;14:5407\u201320. https:\/\/doi.org\/10.1007\/s12652-020-01963-7.","DOI":"10.1007\/s12652-020-01963-7"},{"key":"2025122507573916093_j_dmpt-2025-0049_ref_046","doi-asserted-by":"crossref","unstructured":"Li, J, Jiang, X, Wang, K. Dynamic partitioning of graphs based on multivariate blood glucose data\u00a0\u2013\u00a0a graph neural network model for diabetes prediction. Electronics 2024;13:3727. https:\/\/doi.org\/10.3390\/electronics13183727.","DOI":"10.3390\/electronics13183727"},{"key":"2025122507573916093_j_dmpt-2025-0049_ref_047","doi-asserted-by":"crossref","unstructured":"Haneef, R, Kab, S, Hrzic, R, Fuentes, S, Fosse-Edorh, S, Cosson, E, et al.. Use of artificial intelligence for public health surveillance: a case study to develop a machine learning-algorithm to estimate the incidence of diabetes mellitus in France. Arch Public Health 2021;79:168. https:\/\/doi.org\/10.1186\/s13690-021-00687-0.","DOI":"10.1186\/s13690-021-00687-0"}],"container-title":["Drug Metabolism and Personalized Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/dmpt-2025-0049\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/dmpt-2025-0049\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T07:58:10Z","timestamp":1766649490000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/dmpt-2025-0049\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":47,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,11,18]]},"published-print":{"date-parts":[[2025,12,25]]}},"alternative-id":["10.1515\/dmpt-2025-0049"],"URL":"https:\/\/doi.org\/10.1515\/dmpt-2025-0049","relation":{},"ISSN":["2363-8915"],"issn-type":[{"type":"electronic","value":"2363-8915"}],"subject":[],"published":{"date-parts":[[2025,11,18]]}}}